Hematologic profiles of Beta thalassemia major patients: An institutional cross-sectional study

Dr. Prakhar Gupta, Dhwani Pandya, Dr. Nandini J Desai
{"title":"Hematologic profiles of Beta thalassemia major patients: An institutional cross-sectional study","authors":"Dr. Prakhar Gupta, Dhwani Pandya, Dr. Nandini J Desai","doi":"10.33545/pathol.2023.v6.i2b.519","DOIUrl":null,"url":null,"abstract":"Introduction: Thalassemia is inherited blood disorder characterized by decreased hemoglobin with two main types-alpha and beta thalassemia. There are two main varieties of β thalassaemia, β0 thalassaemia, in which no β globin is produced, and β+ thalassaemia, in which some β globin is produced, but less than normal. As the patient is diagnosed, regular blood transfusions and chelating treatment is given lifelong. In this study, we observed the haematological profiles of multi transfused thalassemia major patients with the accompanying complications. Aims and Objectives: To study the clinical features with RBC parameters, serum ferritin levels, chelation therapy and prevalence of blood transfusion related infection in multi transfused beta thalassemia major patients. Materials and Method: In this cross sectional study, total 90 diagnosed thalassemia major patients were taken with their complete history, physical examination and laboratory parameters such as-complete blood counts. All the patients were monitored for serum ferritin levels and chelation therapy along with screening for transfusion transmitted infections over a year. All the data were compiled and appropriate statistical analysis was done. Results: In present study out of 90 patients, 54 patients were males and 36 patients were females. Mean age of 15.26 ± 7.04 years with 68.9% (N=62) of cases required twice monthly transfusion, 30.0% (n=27) cases required once a month transfusion. 25 cases were found to be HCV+ (27.78%), 3 were HIV + (3.3%) and 62 cases were n on-reactive (68.89%). On first post transfusion CBC we found that 30 cases (33.33%) were found to be adequately transfused with levels > 10 gm%, where as in second results 34 cases (37.78%) were found to be adequately transfused with levels >10 gm%. Mean of average yearly average ferritin values in the study duration was found to be 4724 ± 287.65 ng/mL. The chelating agent dose was with mean 1040 mg and standard deviation 476.19. Conclusion: In the present study, it is concluded that haematological parameters like Haematocrit, Red Blood Cell mass, Haemoglobin and Mean Corpuscular volume had large covariances and Serum Ferritin levels was positively correlated with chelation therapy along with increased rate of transfusion transmitted infections in multi transfused thalassemia major patients.","PeriodicalId":232143,"journal":{"name":"International Journal of Clinical and Diagnostic Pathology","volume":"61 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical and Diagnostic Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33545/pathol.2023.v6.i2b.519","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Thalassemia is inherited blood disorder characterized by decreased hemoglobin with two main types-alpha and beta thalassemia. There are two main varieties of β thalassaemia, β0 thalassaemia, in which no β globin is produced, and β+ thalassaemia, in which some β globin is produced, but less than normal. As the patient is diagnosed, regular blood transfusions and chelating treatment is given lifelong. In this study, we observed the haematological profiles of multi transfused thalassemia major patients with the accompanying complications. Aims and Objectives: To study the clinical features with RBC parameters, serum ferritin levels, chelation therapy and prevalence of blood transfusion related infection in multi transfused beta thalassemia major patients. Materials and Method: In this cross sectional study, total 90 diagnosed thalassemia major patients were taken with their complete history, physical examination and laboratory parameters such as-complete blood counts. All the patients were monitored for serum ferritin levels and chelation therapy along with screening for transfusion transmitted infections over a year. All the data were compiled and appropriate statistical analysis was done. Results: In present study out of 90 patients, 54 patients were males and 36 patients were females. Mean age of 15.26 ± 7.04 years with 68.9% (N=62) of cases required twice monthly transfusion, 30.0% (n=27) cases required once a month transfusion. 25 cases were found to be HCV+ (27.78%), 3 were HIV + (3.3%) and 62 cases were n on-reactive (68.89%). On first post transfusion CBC we found that 30 cases (33.33%) were found to be adequately transfused with levels > 10 gm%, where as in second results 34 cases (37.78%) were found to be adequately transfused with levels >10 gm%. Mean of average yearly average ferritin values in the study duration was found to be 4724 ± 287.65 ng/mL. The chelating agent dose was with mean 1040 mg and standard deviation 476.19. Conclusion: In the present study, it is concluded that haematological parameters like Haematocrit, Red Blood Cell mass, Haemoglobin and Mean Corpuscular volume had large covariances and Serum Ferritin levels was positively correlated with chelation therapy along with increased rate of transfusion transmitted infections in multi transfused thalassemia major patients.
β地中海贫血重症患者血液学特征:一项机构横断面研究
地中海贫血是一种遗传性血液疾病,其特征是血红蛋白减少,主要有两种类型- α和β地中海贫血。β地中海贫血主要有两种类型:β0型地中海贫血,不产生β珠蛋白;β+型地中海贫血,产生一些β珠蛋白,但少于正常水平。在确诊后,患者需要终身接受定期输血和螯合治疗。在这项研究中,我们观察了多次输血地中海贫血患者的血液学特征及其伴随的并发症。目的与目的:探讨多次输血-地中海贫血重症患者红细胞参数、血清铁蛋白水平、螯合治疗及输血相关感染发生率的临床特点。材料与方法:本横断面研究共收集90例确诊地中海贫血重症患者的完整病史、体格检查及全血细胞计数等实验室参数。所有患者在一年内监测血清铁蛋白水平和螯合治疗,并筛查输血传播感染。对所有数据进行整理,并进行相应的统计分析。结果:本组90例患者中,男性54例,女性36例。平均年龄15.26±7.04岁,每月输血2次占68.9% (N=62),每月输血1次占30.0% (N= 27)。HCV阳性25例(27.78%),HIV阳性3例(3.3%),无反应性62例(68.89%)。在第一次输血后的CBC中,我们发现30例(33.33%)被发现以>10 gm%的水平充分输血,而在第二次结果中,34例(37.78%)被发现以>10 gm%的水平充分输血。研究期间平均年平均铁蛋白值的平均值为4724±287.65 ng/mL。螯合剂的平均剂量为1040 mg,标准差为476.19。结论:在本研究中,多次输血的地中海贫血重症患者的血液学参数如红细胞压积、红细胞质量、血红蛋白和平均红细胞体积具有较大的协方差,血清铁蛋白水平与螯合治疗呈正相关,且输血传播感染率增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信